Literature DB >> 18685167

Prenatal sonographic diagnosis of familial Holt-Oram syndrome associated with type B interrupted aortic arch.

K M Law1, K T Tse.   

Abstract

We present a rare case of familial Holt-Oram syndrome diagnosed sonographically at 18 weeks of gestation. The foetus had serious bilateral upper limb malformations, a ventricular septal defect and a type B interrupted aortic arch, while the mother had bilateral upper limb malformations only. The pregnancy was terminated. A pathological and radiological examination of the foetus confirmed the prenatal sonographic findings. Although genetic investigation of TBX5 mutations was not available in our locality at the time of diagnosis, the geneticists made a clinical diagnosis of familial Holt-Oram syndrome. The clinical features of our case completely fulfilled the strict diagnostic criteria for the syndrome. The cardiac malformations most commonly associated with Holt-Oram syndrome are atrial or ventricular septal defects. To the best of our knowledge, a prenatal diagnosis of Holt-Oram syndrome in association with a type B interrupted aortic arch has not been reported in the English literature before.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18685167

Source DB:  PubMed          Journal:  Hong Kong Med J        ISSN: 1024-2708            Impact factor:   2.227


  2 in total

1.  Holt-Oram Syndrome: An Incidental Diagnosis.

Authors:  Mehak Gupta; Ayodeji Dosu; Jayesh Makan
Journal:  Cureus       Date:  2022-05-11

2.  Holt Oram syndrome: a registry-based study in Europe.

Authors:  Ingeborg Barisic; Ljubica Boban; Ruth Greenlees; Ester Garne; Diana Wellesley; Elisa Calzolari; Marie-Claude Addor; Larraitz Arriola; Jorieke Eh Bergman; Paula Braz; Judith Ls Budd; Miriam Gatt; Martin Haeusler; Babak Khoshnood; Kari Klungsoyr; Bob McDonnell; Vera Nelen; Anna Pierini; Annette Queisser-Wahrendorf; Judith Rankin; Anke Rissmann; Catherine Rounding; David Tucker; Christine Verellen-Dumoulin; Helen Dolk
Journal:  Orphanet J Rare Dis       Date:  2014-10-25       Impact factor: 4.123

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.